McKenzie Kathryn B 4
4 · NEOGENOMICS INC · Filed Feb 28, 2018
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-26$8.03/sh+48,000$385,440→ 48,000 totalExercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,000 underlying)
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $9.52From: 2018-10-17Exp: 2022-10-17→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.